Revealing the deeper genome

Depixus Raises USD 35.4M in Series A Financing

December 15, 2021

Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing The financing will support development of a commercial instrument system based on the company’s proprietary and disruptive MAGNA™ technology. MAGNA™ is set to unlock the field of dynamic genomics. Funds raised from a global investor syndicate led by Lansdowne Partners and Bpifrance and supported by …

Depixus® announces peer-reviewed publication describing the detection of sequence variation and base modifications on DNA and RNA using its novel MAGNA technology

March 22, 2021

Novel technology expected to greatly advance the burgeoning field of dynamic genomics. Wide range of possible translational and clinical applications, including virology and epigenetic biomarker discovery for liquid biopsy tests   Paris, France and Cambridge, UK – 18th March 2021 – Depixus®, a biotechnology company developing a unique platform technology for the fast, accurate, and …

Multiple new job openings across our Paris and Cambridge sites

February 15, 2021

We are hiring! We find ourselves in an exciting time as we enter our next phase of growth. We have a range of fantastic vacancies across our Science and Engineering teams as we drive to commercialise our first-generation instrument. If you enjoy working in a fast-paced environment and being part of a highly collaborative and …